NCT04866225View on ClinicalTrials.gov

A Study in Healthy Adult Male Participants to Assess Absorption, Distribution, Metabolism and Excretion (ADME) of Radiolabeled PF-06865571.

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 11, 2021

Primary Completion Date

July 11, 2021

Study Completion Date

August 6, 2021

Conditions
Healthy Participants
Interventions
DRUG

Oral [14C]PF-06865571

Oral radiolabeled PF-06865571

DRUG

Oral PF-06865571

Oral PF-06865571

DRUG

IV [14C]PF-06865571

IV radiolabeled PF-06865571

Trial Locations (1)

53704

Labcorp Clinical Research Unit, Madison

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY